Royalty Pharma PLC (RPRX) To Go Ex-Dividend on November 13th

Royalty Pharma PLC (NASDAQ:RPRX) announced a quarterly dividend on Friday, October 16th. Stockholders of record on Friday, November 13th will be paid a dividend of $0.2350 per share by the biopharmaceutical company on Thursday, December 10th. This represents a $0.94 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, November 13th.

Royalty Pharma has raised its dividend by an average of 0.2% per year over the last three years and has increased its dividend annually for the last 5 consecutive years. Royalty Pharma has a payout ratio of 18.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Royalty Pharma to earn $5.77 per share next year, which means the company should continue to be able to cover its $0.94 annual dividend with an expected future payout ratio of 16.3%.

Royalty Pharma Stock Performance

NASDAQ RPRX opened at $69.45 on Wednesday. The company has a market capitalization of $39.93 billion, a PE ratio of 57.88, a P/E/G ratio of 1.36 and a beta of 0.37. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.29 and a quick ratio of 1.29. Royalty Pharma has a 1 year low of $37.31 and a 1 year high of $69.77. The company has a fifty day moving average of $61.13 and a two-hundred day moving average of $54.10.

Royalty Pharma Company Profile

Royalty Pharma plc is a biopharmaceutical royalty company that provides funding to companies and inventors in exchange for royalty interests in medicines. It acquires existing royalties and helps finance drug development and commercialization through royalty-based transactions and other forms of funding. The company’s portfolio includes royalty interests in medicines across a range of therapeutic areas, spanning both approved treatments and products in development. Royalty Pharma generally earns revenue when these medicines are sold; it does not operate as a conventional drug manufacturer or commercialize medicines itself.